BC
Brandon Capital Partners
Venture CapitalActiveBased in Melbourne, Australia, Brandon Capital Partners is a fund management business focused on investments in life science ventures.
28
Investments
6
Exits
$700M
AUM
21.4%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Brandon Capital Partners.
Investment Thesis & Strategy
Brandon Capital Partners invests in life science ventures, specifically in the biotech sector, and invests at various stages. They are based in Melbourne, Australia.
Investment Activity
Deals per year over the last 11 years
1
20050
20061
20071
20080
20092
20100
20111
20120
20131
20145
2015Portfolio Companies
Selected investments from their portfolio of 28 companies
A
AdAlta
Biotech · Series A, 2015
P
PolyActiva
Biotech · Series A, 2015
P
Paradigm Biopharmaceuticals
Biotech · Series A, 2015
D
Dimerix
Biotech · Series A, 2015
E
Exopharm
Biotech · Series A, 2015
C
Cynata Therapeutics
Biotech · Series A, 2014
S
Spinifex Pharmaceuticals
Biotech · Series A, 2012
O
Opthea
Biotech · Series A, 2010
F
Fibrotech Therapeutics
Biotech · Series A, 2010
A
Avita Medical
Healthcare · Growth, 2008
N
Nanosonics
Healthcare · Growth, 2007
M
Medical Developments International
Healthcare · Growth, 2005
Notable Exits
CompanyTypeYearValue / Acquirer
Fibron Pty LtdAcquisition2017—
AdheriumIPO2016—
Spinifex PharmaceuticalsAcquisition2015—
Medical Developments InternationalIPO2014—
OptheaIPO2014—
NanosonicsIPO2011—
Frequently Asked Questions
Brandon Capital Partners focuses on Series A, Series B, Series C+ stage investments.